#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endologix appoints Guido Neels to its board of directors

Share on Twitter Share on LinkedIn
Staff writer | Irvine, Ca., USA | December 21, 2010
EndologixDecember 21, 2010, Irvine, Ca., USA - Endologix, Inc., a developer of minimally invasive treatments for aortic disorders, announced that Guido Neels has joined the Endologix board of directors.
Mr. Neels currently holds Board positions at ROX Medical, Inc., Entellus Medical, Oraya Therapeutics, Inc., Arsenal Medical and EndGenitor Technologies. Prior to joining Essex Woodlands in 2006, Mr. Neels served as Chief Operating Officer of Guidant Corporation, a world leader in the development of cardiovascular medical products. He was responsible for the global operations of Guidant's four operating units, Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery, and Endovascular Solutions.

He previously served as Group Chairman, Office of the President at Guidant, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. Prior to joining Guidant, Mr. Neels held various general management, sales and marketing positions at Eli Lilly and Co. and held positions in information technology, finance and manufacturing at Raychem Corporation in Belgium and the U.S.

He holds an M.B.A. from Stanford University and a Business Engineering degree from the University of Leuven in Belgium.


 LATEST MOVES FROM California 


MORE INSIDE POST